Last reviewed · How we verify
Placebo vaginal ring
Placebo vaginal ring is a Small molecule drug developed by Organon and Co. It is currently FDA-approved for Placebo control in clinical trials for vaginal ring contraceptives and hormone replacement therapies. Also known as: NuvaRing.
A placebo vaginal ring delivers no active pharmaceutical ingredient and serves as an inert control device for clinical trials.
A placebo vaginal ring delivers no active pharmaceutical ingredient and serves as an inert control device for clinical trials. Used for Placebo control in clinical trials for vaginal ring contraceptives and hormone replacement therapies.
At a glance
| Generic name | Placebo vaginal ring |
|---|---|
| Also known as | NuvaRing |
| Sponsor | Organon and Co |
| Modality | Small molecule |
| Therapeutic area | Contraception / Hormone Therapy |
| Phase | FDA-approved |
Mechanism of action
Placebo vaginal rings are non-medicated devices used in contraceptive and hormone therapy clinical trials to maintain blinding and assess the effect of the ring formulation itself versus active drug. They are inserted into the vagina and remain in place for a specified duration, identical in appearance and handling to active formulations but without therapeutic agents.
Approved indications
- Placebo control in clinical trials for vaginal ring contraceptives and hormone replacement therapies
Common side effects
- Vaginal irritation
- Device expulsion
- Vaginal discomfort
Key clinical trials
- A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix (PHASE3)
- Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery (PHASE4)
- Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia (PHASE3)
- Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users (PHASE2)
- Hysteroscopy Anesthesia for Relief of Pain (NA)
- Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage (PHASE4)
- Vaginal Microbiota Transplant (PHASE1, PHASE2)
- Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo vaginal ring CI brief — competitive landscape report
- Placebo vaginal ring updates RSS · CI watch RSS
- Organon and Co portfolio CI
Frequently asked questions about Placebo vaginal ring
What is Placebo vaginal ring?
How does Placebo vaginal ring work?
What is Placebo vaginal ring used for?
Who makes Placebo vaginal ring?
Is Placebo vaginal ring also known as anything else?
What development phase is Placebo vaginal ring in?
What are the side effects of Placebo vaginal ring?
Related
- Manufacturer: Organon and Co — full pipeline
- Therapeutic area: All drugs in Contraception / Hormone Therapy
- Indication: Drugs for Placebo control in clinical trials for vaginal ring contraceptives and hormone replacement therapies
- Also known as: NuvaRing
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing